Institutional Ownership
Qualigen Therapeutics Inc
CUSIP 74754R301COMAIXCQ1 2026
13D / 13G Filings
2
Schedule 13D/13G on record
Beneficial Filers
1
Distinct reporting persons
Largest Stake
9.1%
Max % of class reported
Institutional Holders
11
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
2 filings · latest Jan 29, 2026
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Geode Capital Management, LLC | 70.5K | $88.1K |
| 2 | Two Sigma Securities, LLC | 13.5K | $16.9K |
| 3 | Goldman Sachs Group Inc | 10.8K | $13.5K |
| 4 | Blackrock, Inc. | 501 | $626 |
| 5 | Harbour Investments, Inc. | 325 | $406 |
| 6 | Highmark Wealth Management LLC | 160 | $200 |
| 7 | Group One Trading LLC | 8 | $10 |
| 8 | Sbi Securities Co., Ltd. | 6 | $8 |
| 9 | Physician Wealth Advisors, Inc. | 2 | $3 |
| 10 | Danske Bank A/S | 1 | $1 |